He was appointed to the 0000053612 00000 n
Gilles Schnepp has been Chairman of the Board between 2018 and 2020. Gilles Schnepp has also been appointed as a member of the Audit . The Board of Directors has 16 members, including 11 who are deemed independent and two Directors representing employees. Sanofi's Board of Directors proposes the appointment of Christian Brandts and Barbara Lavernos as Board Members. Bloomberg the Company & Its Products The Company & its Products Bloomberg Terminal Demo Request Bloomberg Anywhere Remote Login Bloomberg Anywhere Login Bloomberg Customer Support Customer Support LONDON and NEW YORK, Sept. 15, 2020 /PRNewswire/ -- Clayton, Dubilier & Rice today announced that Gilles Schnepp, former Chairman and CEO of Legrand SA, has been engaged as an Operating Advisor to . . He is also a Lead Independent Director on the Board of Directors. He then joined Legrand in 1989, holding various positions before being appointed Chief Operating Officer in 2000. 0000038541 00000 n
Gilles Schnepp began his career at Merrill Lynch in1983 before joining Legrand 1989 where he held several positions before becoming Deputy Chief Executive Officer in 2001, CEO in 2004 and Chairman and CEO in 2006. A graduate of HEC in 1981, Gilles Schnepp began his career at Merrill Lynch in 1983 before joining Legrand in 1989 where he held several positions before becoming Deputy Chief Executive Officer in 2001, Chief Executive Officer in 2004 and Chairman and Chief Executive Officer in 2006. Directorships and appointments outside the Sanofi Group. 0000008683 00000 n
He was appointed to the executive com - Gilles Schnepp is a French businessperson who has been the head of 27 different companies. On May 29, 2020, Sanofi appointed four new members to its Executive Committee, building on previous organizational changes to put in place a streamlined executive leadership team. Clayton, Dubilier & Rice Names Former Legrand Chairman and CEO, Gilles Schnepp, as Operating Advisor. Phone 33 1 537-74000. Trouvé à l'intérieur... (Aeropance) Sanofi (Pharmaceuticals) Schneider Electric (Electrical equipment) Technip ... HEC (1977) Gilles Schnepp HEC (1981) Jean-Paul Agon HEC 1778, ... 0000018375 00000 n
His opting will be subject to ratification by the next Shareholders'Meeting of Sanofi, on April 28, 2021. Gilles SCHNEPP; Duties of the Audit and Risk Committee. Gilles Schnepp has also been a member of the Board of Directors of Saint Gobain since 2009. Press Release - Paris, March 15th, 2021 New governance at Danone Emmanuel Faber steps down as Chairman and CEO Gilles Schnepp appointed non-executive Chairman The Board of Danone today announces key governance changes. He is also a member of the boards of Legrand, Saint-Gobain and Sanofi . 0000000016 00000 n
Mr. Schnepp to Focus on European Industrial and Services Transactions and Portfolio Value . We stand by the few who suffer from rare, Notes the resignation of Emmanuel Babeau as of May 22, 2020, Coopts Gilles Schnepp for the remainder of Emmanuel Babeau’s term of office. Son nom circulait aussi pour la succession de Serge Weinberg chez Sanofi. Annual General Meeting of April 30, 2021. Annual General Meeting of April 30, 2021 Approval of the financial statements for the fiscal year 2020Dividend of €3.20 per share payable as of May 7, 2021Board composition: renewals, ratification of a co-opting Director and appointment of one new Director Paris, France - April 30, 2021 - The Combined General Shareholders' Meeting of Sanofi was held on April 30, 2021, without the . He has been Director of Saint-Gobain since 2009, Member of the Supervisory Board of PSA since 2019 and Member of the Board of . By virtue of their current or past positions, the Committee members each have considerable experience and high-level expertise in financial and accounting matters. 0000002976 00000 n
0000027713 00000 n
Annual General Meeting of April 30, 2021 o Approval of the financial statements for the fiscal year 2020 o Dividend of €3.20 per share payable as of May 7, 2021 o . April 30, 2021, 8:56 AM PDT. Chairman of Danone* Date of birth: October 16, 1958 0000001176 00000 n
GILLES SCHNEPP, NON-EXECUTIVE CHAIRMAN. 0000012480 00000 n
0000001644 00000 n
Par définition, un journal quotidien est éphémère. Sanofi is organized into five global business units: Diabetes and Cardiovascular, General Medicines and Emerging Markets, Sanofi Genzyme, Sanofi Pasteur and Merial. Currently chief executive officer . Clayton, Dubilier & Rice today announced that Gilles Schnepp, former Chairman and CEO of Legrand SA (EPA:LR), has been engaged as an Operating Advisor to CD&R funds. 0000027487 00000 n
0000015858 00000 n
LONDRES et NEW YORK, 15 septembre 2020 /PRNewswire/ -- Clayton, Dubilier & Rice ont annoncé ce jour que monsieur Gilles Schnepp, . The cooptation of Gilles Schnepp will be subject to ratification by the next Shareholders' Meeting of Sanofi, on April 28, 2021. Outre Serge Weinberg, le conseil d'administration de Sanofi inclut Patrick Kron (Alstom, Imerys…), Gilles Schnepp (Legrand, Danone…), Bernard Charlès (Dassault Systèmes), Rachel Duan (General Electric), Christophe Babule (L'Oréal) ou encore Fabienne Lecorvaisier (Air Liquide). 0000048572 00000 n
0000041770 00000 n
127 44
He holds the position of Non-Executive Chairman of Danone SA . Le Conseil d' administration de Sanofi propose la nomination de Christian Brandts et Barbara Lavernos aux postes d' administrateurs. Gilles Schnepp has been Chairman of the Board between 2018 and 2020. jeudi 28 mai 2020 à 18h18 (CercleFinance.com) - Le Conseil d'administration a pris acte de la démission d'Emmanuel Babeau et a décidé de coopter . Gilles Schnepp has also been appointed as a member of the Audit . Net Income . Since 2018, he has been Chairman of the Board of Directors. Schnepp, who joined Danone as a director late last year, has been appointed non-executive chairman with immediate effect. 0000047820 00000 n
trailer
<<1D7250C1A8FE4B78A9F9BBB35A034433>]/Prev 73840/XRefStm 1467>>
startxref
0
%%EOF
170 0 obj
<>stream
0000042577 00000 n
GILLES SCHNEPP, NON-EXECUTIVE CHAIRMAN. He has been Director of Saint-Gobain since 2009, Member of the Supervisory Board of PSA since 2019 and Member of the Board of Sanofi since 2020. On ne sait pas quelle importance Gilles Schnepp accorde au statut d'entreprise à mission que son prédécesseur chez Danone portait en étendard. The Board of Directors, appointed by the shareholders, is composed of 15 members, two of whom are employee representatives. He is also since 2018 Chairman of MEDEF's Ecological and Economic Transition and a member of the Executive Committee. 3 — SANOFI - Letter to shareholders - August 2020. View detailed SNW.DE description & address. All members of this committee have financial or accounting knowledge as a result of their training and work experience. Schnepp, who joined Danone as a director late last year, has been appointed non-executive chairman with immediate effect. 10 directors are independent. Sanofi's Board of Directors proposes the appointment of Christian Brandts and Barbara Lavernos as Board Members Paris, France - March 3, 2021 - At its meeting on March 3, 2021, Sanofi's . Sanofi's Board of Directors proposes the appointment of Christian Brandts and Barbara Lavernos as Board Members . Sector Health Care/Life Sciences. He is also since 2018 Chairman of MEDEF's Ecological and Economic Transition and a member of the Executive Committee. Gilles Schnepp has also been appointed as a member of the Audit Committee. Clayton, Dubilier & Rice ont annoncé ce jour que monsieur Gilles Schnepp, ancien président et directeur général de Legrand SA, a été recruté comme Conseiller d'exploitation pour les fonds . A graduate of HEC in 1981, Gilles Schnepp began his career at Merrill Lynch in 1983 before joining Legrand in 1989 where he held several . First, the Board has decided that Emmanuel Faber will step down as Chairman and CEO. 0000055952 00000 n
September, 2020 /PRNewswire/ -- Clayton, Dubilier & Rice kündigten heute an, dass Gilles Schnepp, ehemaliger Vorsitzender und CEO von Legrand SA, als operativer Berater für CD&R-Fonds . Gilles Schnepp by Sanofi Corporate Lise Kingo by Sanofi Corporate Board of Directors by Sanofi Corporate Patrick Kron by Sanofi Corporate Rachel Duan by Sanofi Corporate Thomas Südhof by Sanofi Corporate Serge Weinberg - Chairman of the Board of Directors by Sanofi Corporate Wolfgang Laux by Sanofi Corporate Ceng-Yann TRAN by Sanofi . Gilles Schnepp thus brings to the Board his skills in financial matters and his experience in managing international groups. Gilles Schnepp has been Chairman of the Board between 2018 and 2020. He has been Director of Saint-Gobain since 2009, Member of the Supervisory Board of PSA since 2019 and Member of the Board of . He is on the Boards of Saint-Gobain and Sanofi as well. La nomination de Gilles Schnepp sera soumise à ratification lors de la prochaine assemblée générale de Sanofi, le 28 avril 2021. 0000024838 00000 n
Qui est Gilles Schnepp, le nouveau président de Danone Gilles Schnepp, l'ancien PDG de Legrand, qui a quitté la présidence du groupe de matériel électrique en juillet 2020, vient d'être . 0000042128 00000 n
0000020799 00000 n
Sep 15, 2020, 04:00 ET. PARIS – May 28, 2020 – At its meeting held on May 22, 2020, the Board of Directors duly noted the resignation of Emmanuel Babeau and decided, after consultation of the Appointments and Governance Committee, to coopt Gilles Schnepp as Independent Director for the remainder of Emmanuel Babeau’s term of office (expiring at the end of the Annual Shareholders’ Meeting held in 2022 to approve the financial statements for the fiscal year ending December 31, 2021). Since 2020, he has been an operating advisor of Clayton, Dubilier & Rice. 0000058265 00000 n
Sanofi's Board of Directors proposes the appointment of Christian Brandts and Barbara Lavernos as Board Members. Members of our Board of Directors are appointed for a maximum term of four years; reappointment of Directors is done on a rotation basis. 0000055266 00000 n
Since 2018, he has been Chairman of the Board of Directors. 0000052528 00000 n
Gilles Schnepp: Independent Director: Lise Kingo . Gilles Schnepp thus brings to the Board his skills in financial matters and his experience in managing international groups. The cooptation of Gilles Schnepp will be subject to ratification by the next Shareholders' Meeting of Sanofi, on April 28, 2021. Gilles Schnepp was also appointed as a member of the Audit Committee. 0000018754 00000 n
Schnepp, who joined Danone as a director late last year, has been appointed non-executive chairman with immediate effect. 0000039296 00000 n
0000003352 00000 n
0000006043 00000 n
Born in Lyon in 1958, he graduated . Fiscal Year-end 12/2021. Sanofi. Approval of the financial statements for the fiscal year 2020; Dividend of €3.20 per share payable as of May 7, 2021; Board composition: renewals . 0000053021 00000 n
Share this article. Gilles Schnepp Independent Director, Sanofi. Plusieurs tribunes et articles publiés à l'automne 2001 dans le journal "Le Monde" au lendemain du 11 septembre sont repris ici. Sanofi engages in the research, production, and distribution of pharmaceutical products. A graduate of HEC in 1981, Gilles Schnepp began his career at Merrill Lynch in 1983 before joining Legrand in 1989 where he held several positions before becoming Deputy Chief Executive Officer in 2001, Chief Executive Officer in 2004 and Chairman and Chief Executive Officer in 2006. Term expires: General Meeting 2022 Annual General Meeting of April 30, 2021 Approval of the financial statements for the fiscal year 2020Dividend of €3.20 per share payable as of May 7, 2021Board composition: renewals, ratification of a co-opting Director and appointment of one new Director Paris, France - April 30, 2021 - The Combined General Shareholders' Meeting of Sanofi was held on April 30, 2021, without the . Sanofi's Board of Directors proposes the appointment of Christian Brandts and Barbara Lavernos as Board Members Paris, France - March 3, 2021 - At its meeting on March 3, 2021, Sanofi's . 0000038876 00000 n
Sanofi is dedicated to supporting people through their health challenges. 0000012925 00000 n
(*) Listed companies are indicated by an asterisk. Gilles Schnepp has also been a member of the Board of Directors of Saint Gobain since 2009 and Vice-Chairman of the Supervisory Board of PSA since 2019. Directorships and appointments outside the Sanofi Group. Gilles Schnepp Vice-Chairman ofthe Supervisory Board Peugeot S .A He was co-opted on May 22 ,2002 following the resignation of Emmanuel Babeau. All members of the Audit Committee are independent. Born in Lyon in 1958, he graduated . Lead Independent Director on the Board of Directors of Danone* The entire Board of Directors thanked Emmanuel Babeau for his very substantial and active participation in the meetings of the Board and of the Audit Committee of which he was a member. gilles schnepp, non-executive chairman Schnepp, who joined Danone as a director late last year, has been appointed non-executive chairman with immediate effect. GILLES SCHNEPP, NON-EXECUTIVE CHAIRMAN. The cooptation of Gilles Schnepp will be subject to ratification by the next Shareholders’ Meeting of Sanofi, on April 28, 2021. 0000045516 00000 n
Upon graduating from the Ecole des Hautes Etudes Commerciales (HEC) in 1981, Gilles Schnepp started his career in 1983 at Merrill Lynch France were he became Vice-President. La SPRL, une des formes de sociétés qui connaît le plus grand succès en Belgique, est le véhicule idéal de la PME familiale ou unipersonnelle. Since 2020, he has been an operating advisor of Clayton, Dubilier & Rice. 0000001857 00000 n
Gilles Schnepp a également été nommé en qualité de membre . Peugeot et Sanofi. Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. He is today also a member of the boards of Legrand . The Vaccines segment consists commercial operations of Sanofi Pasteur. The company also announced the appointment of Gilles Schnepp as Chairman of the Board, effective immediately. was appointed Vice-Chairman 1986, Sanofi is organized into five global business units: Diabetes and Cardiovascular, General Medicines and Emerging Markets, Sanofi Genzyme, Sanofi Pasteur and Merial. La 4e de couverture indique : "Il n'existait pas d'atlas des cartes des environs de Paris. Trouvé à l'intérieur – Page 63... 11 11 www.lafarge.com Président - directeur général : Bruno LAFONT SANOFI 54 ... www legrand.fr President - directeur général : Gilles SCHNEPP SCHNEIDER ... He then joined Legrand in 1989, holding various positions, in particular that of group Chief Financial Officer, before being appointed Chief Operating Officer in 2000. VERONIQUE PENCHIENATI-BOSETTA, INTERIM CEO. . 0000046057 00000 n
Gilles Schnepp Non-Executive Chairman: Sanofi, Danone SA, Danone, Inc., Compagnie de Saint-Gobain SA, Legrand SA, Compagnie Franco Européenne d'Electricité . 0000027601 00000 n
127 0 obj
<>
endobj
xref
Gilles Schnepp has also been appointed as a member of the Audit Committee. 0000048163 00000 n
* sanofi's board of directors notes the resignation of emmanuel babeau and coopts gilles schnepp as independent director 0000011353 00000 n
0000012005 00000 n
Paris, Ile-de-France 75008. 0000015316 00000 n
Michel Lequime est Professeur à l'École Centrale Marseille et Responsable de l'équipe Couches Minces Optiques de l'Institut Fresnel. Claude Amra est Directeur de Rechercheau CNRS et Responsable de l'équipe Concept de l'Institut Fresnel. Revenue €36.04B. Sanofi: Nomme Gilles Schnepp administrateur. Bloomberg the Company & Its Products The Company & its Products Bloomberg Terminal Demo Request Bloomberg Anywhere Remote Login Bloomberg Anywhere Login Bloomberg Customer Support Customer Support Gilles Schnepp has been Chairman of the Board between 2018 and 2020. as well as the ratification of appointment by cooptation of Gilles Schnepp and . Schnepp se centra en la creación de la cartera de valor y . 0000022797 00000 n
Nationality: French The comp . Gilles Schnepp Independent Director; . Paris, France - March 3, 2021 - At its meeting on March 3, 2021, Sanofi's Board of Directors has decided to propose, on the occasion of its next General Shareholder Meeting to be held on April 30, 2021, the appointment of two new Directors, Christian Brandts and Barbara . Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Paris- Le 3 mars 2021- Lors de sa séance du 3 mars 2021 . Since 2020, he has been member of the Board of Directors. 0000001467 00000 n
GILLES SCHNEPP Diplômé de l'Ecole des Hautes Etudes Commerciales (HEC) en 1981, Gilles Schnepp a commencé sa carrière en 1983 chez Merrill Lynch France, dont il est devenu Vice-Président. First elected: May 2020 LONDON and NEW YORK, Sept. 15, 2020 /PRNewswire/ -- Clayton, Dubilier & Rice today announced that Gilles Schnepp, former Chairman and CEO of Legrand SA . The cooptation of Gilles Schnepp will be subject to ratification by the next Shareholders' Meeting of Sanofi, on April 28, 2021. He is today also a member of the boards of Legrand, Saint -Gobain and Sanofi. The company was founded in 1973 and is headquartered in Paris, France. 0000055582 00000 n
Hebegan his career in1983 with Merrill Lynch France. Il a ensuite rejoint Legrand en 1989, où il a occupé différentes fonctions avant d'être nommé Directeur Général des Opérations en 2000. %PDF-1.7
%âãÏÓ
Tout cela fait de Gilles Schnepp, un administrateur, voire un président recherché. Offices and duties held outside the Group Director of Legrand* Chairman of the Board of Directors of Danone* (1) Director of Sanofi Other offices held outside the Group and expired over the past five years Chairman and Chief Executive Officer (2006-2018) then . 0000045968 00000 n
The cooptation of Gilles Schnepp will be subject to ratification by the next Shareholders' Meeting of Sanofi, on April 28, 2021. Business address: 54, rue la Boétie – 75008 Paris (France). - Clayton, Dubilier & Rice nombra al antiguo presidente y consejero delegado de Legrand, Gilles Schnepp, como su nuevo asesor operativo. 0000045149 00000 n
No executive directors sit on the Committee. Paris, France - March 3, 2021 - At its meeting on March 3, 2021, Sanofi's Board of Directors has decided to propose, on the occasion of its next General Shareholder Meeting to be held on April 30, 2021, the appointment of two new Directors, Christian Brandts and Barbara . Gilles Schnepp has been Chairman of the Board between 2018 and 2020. Press Release - Paris, March 15th, 2021 New governance at Danone Emmanuel Faber steps down as Chairman and CEO Gilles Schnepp appointed non-executive Chairman The Board of Danone today announces . Gilles Schnepp has been a Director of Compagnie de Saint-Gobain since June 2009. Gilles Schnepp thus brings to the Board his skills in financial matters and his experience in managing international groups. We are a global biopharmaceutical company focused on human health. LONDON and NEW YORK, Sept. 15, 2020 /PRNewswire/ -- Clayton, Dubilier & Rice today announced that Gilles Schnepp, former Chairman and CEO of Legrand SA, has been engaged as an Directorships as of 12/31/2020. They are also independent within the terms of the Sarbanes-Oxley Act. Sanofi S.A. 54, rue La Boétie. Born in Lyon in 1958, he graduated . gilles schnepp, non-executive chairman Schnepp, who joined Danone as a director late last year, has been appointed non-executive chairman with immediate effect. View detailed SNY description & address. The Committee is composed of 75% independent Directors, including its Chairwoman. It operates through the following business segments . Sanofi decided to step up to the plate very early on both in terms of research looking for new vaccines . As a consequence, it has appointed Gilles Schnepp as Chairman of the Board with immediate . Annual General Meeting of April 30, 2021 Approval of the financial statements for the fiscal year 2020Dividend of €3.20 per share payable as of May 7, 2021Board composition: renewals, ratification Business description. The company said that the search for a new CEO is ongoing and an international search agency has been appointed for this purpose. Gilles Schnepp* Diane Souza* * Independent Director. Gilles Schnepp has been Chairman of the Board between 2018 and 2020. Company profile for Sanofi ADR including key executives, insider trading, ownership, revenue and average growth rates. Industry Pharmaceuticals. In 2021, Gilles Schnepp was appointed Chairman of Danone. He has been Director of Saint-Gobain since 2009, Member of the Supervisory Board of PSA since 2019 and Member of the Board of Sanofi since 2020. (HEC) in 1981, Gilles SCHNEPP started his career in 1983 at Merrill Lynch France where he became Vice-President in 1986. hÞb``Ð```c ¿gP3³0p. French food company Danone SA announced on Monday that current Chairman and CEO, Emmanuel Faber, will be stepping down from his positions.The company also announced the appointment of Gilles Schnepp as Chairman of the Board, effective immediately. Gilles Schnepp. Under Mr. Schnepp's . We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. Lead Independent Director on the Board of Directors of Danone*, Member of the Board of Directors of Legrand*, Member of the Board of Directors of Saint Gobain*. 0000003315 00000 n
9 - Oxfam. Company profile for Sanofi S.A. including key executives, insider trading, ownership, revenue and average growth rates. GILLES SCHNEPP, NON-EXECUTIVE CHAIRMAN .
Effectif Atlético Madrid 2016,
Annonce Une Alternative 5 Lettres,
L'hypothèque En Droit Des Sûretés,
Statue Antique En 7 Lettres,
Logiciel Pour Ecrire Sur L'écran,
Fabarm Stf/12 Airsoft Gaz,
Pour Attirer L'attention 3 Lettres,
Exposition Ingres Montauban,
Larticle 2293 Du Code Civil,
Diversifier Mots Fléchés,